| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures
|
Neutel, Joel M.
|
|
2013
|
4 |
2 |
p. 269-283
|
artikel
|
| 2 |
Adherence to Therapies in Patients with Type 2 Diabetes
|
García-Pérez, Luis-Emilio
|
|
2013
|
4 |
2 |
p. 175-194
|
artikel
|
| 3 |
Age-Specific Effectiveness and Safety of Newly Initiated Insulin Therapy in Japanese Patients with Uncontrolled Diabetes
|
Shiga, Takayoshi
|
|
2013
|
4 |
2 |
p. 473-486
|
artikel
|
| 4 |
Annual Medical Costs of Swedish Patients with Type 2 Diabetes Before and After Insulin Initiation
|
Bexelius, Christin
|
|
2013
|
4 |
2 |
p. 363-374
|
artikel
|
| 5 |
Clinical Experience with Insulin Detemir in Patients with Type 2 Diabetes from the Near East Countries
|
Echtay, Akram
|
|
2013
|
4 |
2 |
p. 399-408
|
artikel
|
| 6 |
Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin
|
Tatosian, Daniel A.
|
|
2013
|
4 |
2 |
p. 431-442
|
artikel
|
| 7 |
Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
|
Kusunoki, Yoshiki
|
|
2013
|
4 |
2 |
p. 461-472
|
artikel
|
| 8 |
Efficacy of Initial Basal-Supported Oral Therapy with Sitagliptin in Untreated Type 2 Diabetes
|
Yoshioka, Keiji
|
|
2013
|
4 |
2 |
p. 409-416
|
artikel
|
| 9 |
Erratum to: Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies
|
Engel, Samuel S.
|
|
2013
|
4 |
2 |
p. 487
|
artikel
|
| 10 |
Experience with Vildagliptin in Patients ≥75 Years with Type 2 Diabetes and Moderate or Severe Renal Impairment
|
Schweizer, Anja
|
|
2013
|
4 |
2 |
p. 257-267
|
artikel
|
| 11 |
Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study
|
Halimi, Serge
|
|
2013
|
4 |
2 |
p. 385-398
|
artikel
|
| 12 |
Incretin-Based Therapies: Focus on Effects Beyond Glycemic Control Alone
|
Davidson, Jaime A.
|
|
2013
|
4 |
2 |
p. 221-238
|
artikel
|
| 13 |
Incretin Therapy for Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin
|
Mezquita Raya, Pedro
|
|
2013
|
4 |
2 |
p. 417-430
|
artikel
|
| 14 |
Initial Management of Severe Hyperglycemia in Patients with Type 2 Diabetes: an Observational Study
|
King, William M.
|
|
2013
|
4 |
2 |
p. 375-384
|
artikel
|
| 15 |
Insulin Degludec: A Significant Advancement in Ultralong-Acting Basal Insulin
|
Kalra, Sanjay
|
|
2013
|
4 |
2 |
p. 167-173
|
artikel
|
| 16 |
Management of Type 2 Diabetes Mellitus in Older Patients: Current and Emerging Treatment Options
|
Moghissi, Etie
|
|
2013
|
4 |
2 |
p. 239-256
|
artikel
|
| 17 |
Physician Preferences for Extra-Glycemic Effects of Type 2 Diabetes Treatments
|
Poulos, Christine
|
|
2013
|
4 |
2 |
p. 443-459
|
artikel
|
| 18 |
Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: A1chieve Sub-Analysis
|
Khamseh, Mohammad Ebrahim
|
|
2013
|
4 |
2 |
p. 347-361
|
artikel
|
| 19 |
Safety and Effectiveness of Switching from a Basal-only to Biphasic Insulin Aspart 30 Insulin Regimen
|
Haddad, Jihad
|
|
2013
|
4 |
2 |
p. 309-319
|
artikel
|
| 20 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
|
Heise, Tim
|
|
2013
|
4 |
2 |
p. 331-345
|
artikel
|
| 21 |
Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus
|
Bays, Harold
|
|
2013
|
4 |
2 |
p. 195-220
|
artikel
|
| 22 |
Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE
|
Mathieu, Chantal
|
|
2013
|
4 |
2 |
p. 285-308
|
artikel
|
| 23 |
Vildagliptin is Effective for Glycemic Control in Diabetic Patients Undergoing either Hemodialysis or Peritoneal Dialysis
|
Ito, Hiroyuki
|
|
2013
|
4 |
2 |
p. 321-329
|
artikel
|
Tijdschrift beschrijving